These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 13212944)

  • 1. Prostatic cancer. III. Advantages of large oral dosage of diethylstilbestrol.
    FISH GW; HUDSON PB; JOST HM
    J Urol; 1954 Dec; 72(6):1222-3. PubMed ID: 13212944
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cancer of the lung metastatic from the prostate; disappearance of the radiological images after diethylstilbestrol therapy].
    MEYER A; HINAUT G; LIOT F
    Bull Mem Soc Med Hop Paris; 1951 Oct 19-26; 67(27-28):1190-5. PubMed ID: 14925878
    [No Abstract]   [Full Text] [Related]  

  • 3. Chemotherapeutic aspects in the treatment of prostatic cancer.
    HASCHE-KLUNDER R; WILMANNS H
    Br J Urol; 1957 Mar; 29(1):20-4. PubMed ID: 13413208
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of diethylstilbestrol and estramustine phosphate on serum sex hormone binding globulin and testosterone levels in prostate cancer patients.
    Karr JP; Wajsman Z; Kirdani RY; Murphy GP; Sandberg AA
    J Urol; 1980 Aug; 124(2):232-6. PubMed ID: 7190620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Secondary cancer of the lung of prostatic origin; recovery maintained for 3 years by diethylstilbestrol therapy].
    MEYER A; LIOT F
    Bull Mem Soc Med Hop Paris; 1954 Mar 26-Apr 9; 70(11-12):401-4. PubMed ID: 13172629
    [No Abstract]   [Full Text] [Related]  

  • 6. Biologic titration of diethylstilbestrol against activity of prostatic cancer: effect on serum aldolase.
    BAKER R; GOVAN D; HUFFER J; CASON J
    J Clin Endocrinol Metab; 1953 Apr; 13(4):383-91. PubMed ID: 13052668
    [No Abstract]   [Full Text] [Related]  

  • 7. Endocrine changes after diethylstilbestrol therapy. Effects on prostatic neoplasm and pituitary-gonadal axis.
    Prout GR; Kliman B; Daly JJ; MacLaughlin RA; Griffin PP; Young HH
    Urology; 1976 Feb; 7(2):148-55. PubMed ID: 1246784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Contribution to the honvan treatment of prostatic carcinoma].
    FULAR W
    Medizinische; 1956 Feb; (8):285-8. PubMed ID: 13321398
    [No Abstract]   [Full Text] [Related]  

  • 9. [New methods of treatment of prostatic carcinoma].
    HASCHE-KLUNDER R; GACA A
    Med Klin; 1955 Dec; 50(48):2032-5. PubMed ID: 13287784
    [No Abstract]   [Full Text] [Related]  

  • 10. [Metastatic prostate cancer. High-dose diethylstilbestrol and hormonal escape].
    Chaouat D; Court B
    Rev Rhum Ed Fr; 1994 Apr; 61(4):290. PubMed ID: 7920531
    [No Abstract]   [Full Text] [Related]  

  • 11. Carcinoma of the prostate.
    RICHES EW
    Br J Clin Pract; 1956 Nov; 10(11):729; passim. PubMed ID: 13374182
    [No Abstract]   [Full Text] [Related]  

  • 12. Endocrine treatment of prostatic cancer.
    Pollen JJ
    Urology; 1983 Jun; 21(6):555-8. PubMed ID: 6868224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advanced prostatic carcinoma; a study of ten-year survival after antiandrogenic treatment.
    GANEM EJ
    N Engl J Med; 1956 Jun; 254(23):1086-7. PubMed ID: 13322216
    [No Abstract]   [Full Text] [Related]  

  • 14. [Cancer of the prostate treated with 1 mg per day of diethylstilbestrol. Value of the determination of salivary free testosterone].
    Steg A; Laudat MH; Zerbib M; Guiban D
    Presse Med; 1988 Feb; 17(6):282. PubMed ID: 2964628
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of flutamide (SCH-13521) and diethylstilbestrol in untreated advanced prostatic cancer.
    Jacobo E; Schmidt JD; Weinstein SH; Flocks RH
    Urology; 1976 Sep; 8(3):231-3. PubMed ID: 788293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endocrine therapy in the management of prostatic cancer.
    HECKEL NJ
    J Clin Endocrinol Metab; 1953 Feb; 13(2):228-30. PubMed ID: 13034908
    [No Abstract]   [Full Text] [Related]  

  • 17. A comparison of the effect of diethylstilbestrol with low dose estramustine phosphate in the treatment of advanced prostatic cancer: final analysis of a phase III trial of the European Organization for Research on Treatment of Cancer.
    Smith PH; Suciu S; Robinson MR; Richards B; Bastable JR; Glashan RW; Bouffioux C; Lardennois B; Williams RE; de Pauw M
    J Urol; 1986 Sep; 136(3):619-23. PubMed ID: 3525866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endocrine inhibition as related to carcinoma of the prostate.
    VALK WL; OWENS RH
    J Urol; 1954 Sep; 72(3):516-24. PubMed ID: 13202240
    [No Abstract]   [Full Text] [Related]  

  • 19. [Initial experiments with the therapeutic applications of sexoclasia].
    WALLON H
    Scalpel (Brux); 1954 Oct; 107(44):1147-61. PubMed ID: 13225593
    [No Abstract]   [Full Text] [Related]  

  • 20. [Hemorrhagic diathesis in prostate carcinoma and its treatment].
    COTTIER P; LEUPOLD R; SCHEITLIN W
    Schweiz Med Wochenschr; 1955 Aug; 85(33):781-6. PubMed ID: 13255831
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.